Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinical review of 1,082 patients

BACKGROUND: Although the outcomes of pancreatic cancer have been improved by gemcitabine, the changes in its characteristics and long-term outcomes within the gemcitabine era remain unclear. This study was conducted to identify clinical characteristics of pancreatic cancer patients within the gemcit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuroda, Taira, Kumagi, Teru, Yokota, Tomoyuki, Seike, Hirotaka, Nishiyama, Mari, Imai, Yusuke, Inada, Nobu, Shibata, Naozumi, Imamine, Satoshi, Okada, Shin-ichi, Koizumi, Mitsuhito, Yamanishi, Hirofumi, Azemoto, Nobuaki, Miyaike, Jiro, Tanaka, Yoshinori, Tatsukawa, Haruka, Utsunomiya, Hiroki, Ohno, Yoshinori, Miyake, Teruki, Hirooka, Masashi, Furukawa, Shinya, Abe, Masanori, Ikeda, Yoshiou, Matsuura, Bunzo, Hiasa, Yoichi, Onji, Morikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766232/
https://www.ncbi.nlm.nih.gov/pubmed/24256464
http://dx.doi.org/10.1186/1471-230X-13-134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766232/
https://www.ncbi.nlm.nih.gov/pubmed/24256464
http://dx.doi.org/10.1186/1471-230X-13-134

Ejemplares similares